Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 711 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Liminatus Pharma, Inc. Class A Common Stock
Market Cap
$5.17M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$5.21M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.24M
Operating Margin
0.00%
TTM Avg
-62.53%
3Y Avg
-159.78%
5Y Avg
-184.56%
Market Cap
$5.26M
Operating Margin
-305.03%
TTM Avg
-323.91%
3Y Avg
-495.10%
5Y Avg
-376.97%
Market Cap
$5.06M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1246.08%
5Y Avg
-2147.17%
Market Cap
$5.29M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.05M
Operating Margin
-3317.65%
TTM Avg
-1658.83%
3Y Avg
-2341.84%
5Y Avg
-1561.23%
Market Cap
$5.01M
Operating Margin
-19.28%
TTM Avg
1.28%
3Y Avg
11.60%
5Y Avg
11.60%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | $5.17M | 0.00% | 0.00% | 0.00% | N/A |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Pulmatrix, Inc. (PULM)vs › | $5.24M | 0.00% | -62.53% | -159.78% | -184.56% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.26M | -305.03% | -323.91% | -495.10% | -376.97% |
| Imunon, Inc. (IMNN)vs › | $5.06M | 0.00% | 0.00% | -1246.08% | -2147.17% |
| Alzamend Neuro Inc (ALZN)vs › | $5.29M | 0.00% | 0.00% | 0.00% | 0.00% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.05M | -3317.65% | -1658.83% | -2341.84% | -1561.23% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.01M | -19.28% | 1.28% | 11.60% | 11.60% |
| CalciMedica, Inc. (CALC)vs › | $4.82M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.77M | -1683.01% | -1461.09% | -2100.59% | -1711.35% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
